These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28655760)

  • 1. Silencing of solute carrier family 13 member 5 disrupts energy homeostasis and inhibits proliferation of human hepatocarcinoma cells.
    Li Z; Li D; Choi EY; Lapidus R; Zhang L; Huang SM; Shapiro P; Wang H
    J Biol Chem; 2017 Aug; 292(33):13890-13901. PubMed ID: 28655760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flipping a citrate switch on liver cancer cells.
    Peters JM
    J Biol Chem; 2017 Aug; 292(33):13902-13903. PubMed ID: 28821606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
    Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
    Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD.
    Sun Q; Niu Q; Guo Y; Zhuang Y; Li X; Liu J; Li N; Li Z; Huang F; Qiu Z
    J Agric Food Chem; 2021 Aug; 69(31):8714-8725. PubMed ID: 34323067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver.
    Li L; Li H; Garzel B; Yang H; Sueyoshi T; Li Q; Shu Y; Zhang J; Hu B; Heyward S; Moeller T; Xie W; Negishi M; Wang H
    Mol Pharmacol; 2015 Apr; 87(4):674-82. PubMed ID: 25628225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomic analysis of SLC13A5 knockdown reveals elevated ketogenesis and enhanced cellular toxic response to chemotherapeutic agents in HepG2 cells.
    Hu T; Huang W; Li Z; Kane MA; Zhang L; Huang SM; Wang H
    Toxicol Appl Pharmacol; 2020 Sep; 402():115117. PubMed ID: 32634519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bempedoic Acid Unveils Therapeutic Potential in Non-Alcoholic Fatty Liver Disease: Suppression of the Hepatic PXR-SLC13A5/ACLY Signaling Axis.
    Sun Q; Guo Y; Hu W; Zhang M; Wang S; Lei Y; Meng H; Li N; Xu P; Li Z; Lin H; Huang F; Qiu Z
    Drug Metab Dispos; 2023 Dec; 51(12):1628-1641. PubMed ID: 37684055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions.
    Kumar A; Cordes T; Thalacker-Mercer AE; Pajor AM; Murphy AN; Metallo CM
    Cell Rep; 2021 Sep; 36(11):109701. PubMed ID: 34525352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin.
    Kopel J; Higuchi K; Ristic B; Sato T; Ramachandran S; Ganapathy V
    Sci Rep; 2020 May; 10(1):8536. PubMed ID: 32444674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of a species-specific inhibitor selective for human Na+-coupled citrate transporter (NaCT/SLC13A5/mINDY).
    Higuchi K; Kopel JJ; Sivaprakasam S; Jaramillo-Martinez V; Sutton RB; Urbatsch IL; Ganapathy V
    Biochem J; 2020 Nov; 477(21):4149-4165. PubMed ID: 33079129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Membrane Na⁺-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy.
    Bhutia YD; Kopel JJ; Lawrence JJ; Neugebauer V; Ganapathy V
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
    Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes.
    Li Z; Li L; Heyward S; Men S; Xu M; Sueyoshi T; Wang H
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
    Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
    Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
    Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
    Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
    FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood-brain barrier.
    Kopel JJ; Bhutia YD; Sivaprakasam S; Ganapathy V
    Biochem J; 2021 Feb; 478(3):463-486. PubMed ID: 33544126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.